Evidence map›Paper›PMID 25774088›Full record

ArticleBMC anesthesiology2015

Effect of apoptosis in neural stem cells treated with sevoflurane.

Jianlei Qiu, Pengcai Shi, Wude Mao, Yuyi Zhao, Wenshuai Liu, Yuelan Wang

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in BMC anesthesiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. GABATranslational psychiatry · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jianlei QiuDepartment of Anesthesiology, Dezhou People's Hospital, Dezhou, Shandong China ; School of Medicine, Shandong University, Ji'nan, Shandong China.
Pengcai ShiDepartment of Anesthesiology, Shandong Provincial Qianfoshan Hospital, Ji'nan, Shandong China.
Wude MaoDepartment of Anesthesiology, Jiaozhou Central Hospital of Qingdao, Qingdao, Shandong China.
Yuyi ZhaoDepartment of Anesthesiology, Dezhou People's Hospital, Dezhou, Shandong China.
Wenshuai LiuDepartment of Emergency, Dezhou People's Hospital, Dezhou, Shandong China.
Yuelan WangSchool of Medicine, Shandong University, Ji'nan, Shandong China ; Department of Anesthesiology, Shandong Provincial Qianfoshan Hospital, Ji'nan, Shandong China.
Dezhou University · CNShandong Provincial QianFoShan Hospital · CNShuozhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAt present, sevoflurane inhalation anesthesia used on infants is well-known. But long-time exposure to inhalation anesthetic could cause neurologic disorder, especially nerve degeneration in infant and developing brain. The central nervous system degeneration of infants could affect the memory and cognitive function. γ-Aminobutyric acid (GABA) is a known inhibitory neurotransmitter in central nervous system. Inhalation anesthetic sevoflurane may activate GABAA receptor to inhibit central nervous system, leading to apoptosis of neural degeneration, cognitive dysfunction in the critical period of brain development.

methodsNeural stem cells were derived from Wistar embryos, cultured in vitro. Third generation of neural stem cells were randomly divided into four groups according to cultured suspension: Sevoflurane group (Group S), GABAA receptor antagonists, Bicuculline group (Group B), Sevoflurane + GABAA receptor antagonists, Bicuculline group (Group S + B), dimethyl sulphoxide (DMSO) group (Group D). Group B and Group D did not receive sevoflurane preconditioning. Group S and Group S + B were pretreated with 1 minimum alveolar concentration (MAC) sevoflurane for 0 h, 3 h, 6 h, and 12 h. Group S + B and Group B were pretreated with bicuculline (10 uM). Group D was treated with DMSO (10 uL/mL). After treatments above, all groups were cultured for 48 h. Then we measured the cells viability by Cell Counting Kit (CCK-8) assay, cytotoxicity by Lactate Dehydrogenase (LDH) assay, apoptosis ratio with Annexin V/propidium iodide (PI) staining by flow cytometry, and the expression of GABAAR, anti-apoptotic protein Bcl-2, pro-apoptotic protein Bax and Caspase-3 by western blotting.

resultsAfter exposing to sevoflurane for 0 h, 3 h, 6 h, and 12 h with 1MAC, we found that cell viability obviously decreased and cytotoxicity increased in time-dependent way. And Annexin V/PI staining indicated increased apoptosis ratio by flow cytometry. The protein level of GABAA receptor, pro-apoptotic protein Bax and apoptosis protein Caspase-3 increased; while anti-apoptotic protein Bcl-2 decreased. And bicuculline could reverse all detrimental results caused by sevoflurane.

conclusionSevoflurane can inhibit the central nervous system by activating GABAA, resulting in apoptosis of neural stem cells, thus leading to the NSCs degeneration.

Indexed as

AnimalsApoptosisbcl-2-Associated X ProteinBicucullineCaspase 3Cells, CulturedCell SurvivalMethyl EthersNeural Stem CellsProto-Oncogene Proteins c-bcl-2RatsReceptors, GABA-ASevofluranebcl-2-Associated X ProteinBicucullineCaspase 3Methyl EthersProto-Oncogene Proteins c-bcl-2Receptors, GABA-ASevofluraneApoptosisNeural Stem CellsSevofluraneγ-Aminobutyric acid

Identifiers

PMID25774088
PMCPMC4359390
OpenAlexW2132525688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.